Changjiang Pharmaceutical Group バランスシートの健全性
財務の健全性 基準チェック /16
Changjiang Pharmaceutical Group has a total shareholder equity of CN¥737.2M and total debt of CN¥787.8M, which brings its debt-to-equity ratio to 106.9%. Its total assets and total liabilities are CN¥3.1B and CN¥2.4B respectively.
主要情報
106.9%
負債資本比率
CN¥787.84m
負債
| インタレスト・カバレッジ・レシオ | n/a |
| 現金 | CN¥6.74m |
| エクイティ | CN¥737.22m |
| 負債合計 | CN¥2.35b |
| 総資産 | CN¥3.09b |
財務の健全性に関する最新情報
更新なし
Recent updates
Revenues Not Telling The Story For Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) After Shares Rise 45%
Sep 30
Investors Don't See Light At End Of Changjiang Pharmaceutical Group Co., Ltd.'s (SZSE:300391) Tunnel And Push Stock Down 31%
Aug 11Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 29% But Perhaps Not Attractive Enough
Jun 17Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough
Apr 17Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Not Doing Enough For Some Investors As Its Shares Slump 25%
Feb 27財務状況分析
短期負債: 300391's short term assets (CN¥1.8B) do not cover its short term liabilities (CN¥1.8B).
長期負債: 300391's short term assets (CN¥1.8B) exceed its long term liabilities (CN¥522.5M).
デット・ツー・エクイティの歴史と分析
負債レベル: 300391's net debt to equity ratio (106%) is considered high.
負債の削減: 300391's debt to equity ratio has increased from 16.6% to 106.9% over the past 5 years.
貸借対照表
キャッシュ・ランウェイ分析
過去に平均して赤字であった企業については、少なくとも1年間のキャッシュ・ランウェイがあるかどうかを評価する。
安定したキャッシュランウェイ: 300391 has less than a year of cash runway based on its current free cash flow.
キャッシュランウェイの予測: 300391 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 46.3% each year